Keytruda

dart board miss failure
Favicon Fierce Pharma

Merck's Welireg surprisingly fails in first-line kidney cancer

Welireg's phase 3 flop in first-line kidney cancer comes as a surprise following two late-stage trial wins in the second-line and adjuvant settings.
Angus Liu Apr 21, 2026 10:00am
Golfer devastated after just barely missing a putt

Immutep's ph. 3 failure surprises analysts, sinks stock

Mar 13, 2026 9:53am
Keytruda

Agilent diagnostic lands FDA nod alongside Keytruda expansion

Feb 12, 2026 9:05am
yellow road to bright light

Rakuten lights path to 2028 FDA filing with fresh $100M raise

Jan 7, 2026 9:43am
cancer ribbons world cancer day cancer awareness

Promega wins FDA OK as Keytruda-Lenvima companion diagnostic

Nov 13, 2025 4:00am
Pfizer

Pfizer lays out its PD-1xVEGF bispecific research strategy

Nov 11, 2025 11:43am